Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases.
Carlson
R P
RP
Wyeth-Ayerst Research, Princeton, New Jersey 08543-8000.
Baeder
W L
WL
Caccese
R G
RG
Warner
L M
LM
Sehgal
S N
SN
D000284:Administration, Oral; D000818:Animals; D001168:Arthritis / Q000188:drug therapy*; D001169:Arthritis, Experimental / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004326:Drinking / Q000187:drug effects; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy; D005260:Female; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D016688:Mice, Inbred NOD; D011090:Polyenes / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus